n,n-dimethylacrylamide has been researched along with Coronary Restenosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masuda, T; Nakayama, Y | 1 |
1 other study(ies) available for n,n-dimethylacrylamide and Coronary Restenosis
Article | Year |
---|---|
Development of a water-soluble matrix metalloproteinase inhibitor as an intra-arterial infusion drug for prevention of restenosis after angioplasty.
Topics: Acrylamides; Angioplasty, Balloon, Coronary; Benzamides; Coronary Restenosis; Humans; Hydroxamic Acids; Infusions, Intra-Arterial; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Polymers; Postoperative Complications; Protease Inhibitors; Solubility; Spectrophotometry, Ultraviolet; Stents; Stereoisomerism; Vinyl Compounds; Water | 2003 |